Antibiotic resistance is a complication of treating patients in the intensive care unit (ICU) who have contracted healthcare-acquired infections (HAIs), but according to Marie-Laurence Lambert, MD, of the of the Scientific Institute of Public Health in Brussels, and colleagues, this resistance does not increase mortality. The research was published online in Lancet Infectious Diseases.
In their study, Lambert, et al. (2010) sought to assess excess mortality and length of stay in intensive-care units from bloodstream infections and pneumonia. The researchers analysed data collected prospectively from ICUs that reported according to the European standard protocol for surveillance of HAIs, focusing on the most frequent causative microorganisms. Resistance was defined as resistance to ceftazidime (Acinetobacter baumannii or Pseudomonas aeruginosa), third-generation cephalosporins (Escherichia coli), and oxacillin (Staphylococcus aureus). The researchers defined 20 different exposures according to infection site, microorganism and resistance status. For every exposure, the researchers compared outcomes between patients exposed and unexposed by use of time-dependent regression modelling, and adjusted results for patients' characteristics and time-dependency of the exposure.
The researchers report that they obtained data for 119,699 patients who were admitted for more than two days to 537 ICUs in 10 countries between Jan 1, 2005, and Dec 31, 2008. Excess risk of death (hazard ratio) for pneumonia in the fully adjusted model ranged from 1·7 (95% CI 1·41·9) for drug-sensitive S aureus to 3·5 (2·94·2) for drug-resistant P aeruginosa. For bloodstream infections, the excess risk ranged from 2·1 (1·62·6) for drug-sensitive S aureus to 4·0 (2·75·8) for drug-resistant P aeruginosa. Risk of death associated with antimicrobial resistance (ie, additional risk of death to that of the infection) was 1·2 (1·11·4) for pneumonia and 1·2 (0·91·5) for bloodstream infections for a combination of all four microorganisms, and was highest for S aureus (pneumonia 1·3 [1·01·6], bloodstream infections 1·6 [1·12·3]). Antimicrobial resistance did not significantly increase length of stay; the hazard ratio for discharge, dead or alive, for sensitive microorganisms compared with resistant microorganisms (all four combined) was 1·05 (0·971·13) for pneumonia and 1·02 (0·981·17) for bloodstream infections. P aeruginosa had the highest burden of HAIs because of its high prevalence and pathogenicity of both its drug-sensitive and drug-resistant strains.
The researchers conclude that healthcare-acquired bloodstream infections and pneumonia greatly increase mortality and pneumonia increases length of stay in intensive-care units, but that the additional effect of the most common antimicrobial resistance patterns is comparatively low.
Reference: Lambert ML, Suetens C, Savey A, Palomar M, Hiesmayr M, Morales I, Agodi A, Frank U, Mertens K, Schumacher M and Wolkewitz M. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. The Lancet Infectious Diseases. Dec. 1, 2010.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.